This page shows the latest Marstacimab news and features for those working in and with pharma, biotech and healthcare.
It will compare marstacimab to a run-in period on replacement therapy with VIII or IX clotting factor, respectively, or bypass therapy. ... Marstacimab offers a new way of treating haemophilia that does not rely on replacing factor VIII or factor IX.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...